Literature DB >> 10806197

Phosphorylation of human glutamine:fructose-6-phosphate amidotransferase by cAMP-dependent protein kinase at serine 205 blocks the enzyme activity.

Q Chang1, K Su, J R Baker, X Yang, A J Paterson, J E Kudlow.   

Abstract

Glutamine:fructose-6-phosphate amidotransferase (GFAT) is the rate-limiting enzyme in glucosamine synthesis. Prior studies from our laboratory indicated that activation of adenylate cyclase was associated with depletion of O-GlcNAc modification. This finding and evidence that human GFAT (hGFAT) might be regulated by cAMP-dependent protein kinase (PKA) led us to investigate the role of PKA in hGFAT function. We confirmed that adenylate cyclase activation by forskolin results in diminished O-GlcNAc modification of several cellular proteins which can be overcome by exposure of the cells to glucosamine but not glucose, suggesting the PKA activation results in depletion of UDP-GlcNAc for O-glycosylation. To determine if GFAT is indeed regulated by PKA, we expressed the active form of the enzyme using a vaccinia virus expression system and showed that the activity of the enzyme was to decrease to undetectable levels by PKA phosphorylation. We mapped the PKA phosphorylation sites with the aid of matrix-assisted laser desorption ionization mass spectroscopy and showed that the protein was stoichiometrically phosphorylated at serine 205 and also phosphorylated, to a lesser extent at serine 235. Mutagenesis studies indicated that the phosphorylation of serine 205 by PKA was necessary for the observed inhibition of enzyme activity while serine 235 phosphorylation played no observable role. The activity of GFAT is down-regulated by cAMP, thus placing regulation on the hexosamine pathway that is in concert with the energy requirements of the organism. During starvation, hormones acting through adenylate cyclase could direct the flux of glucose metabolism into energy production rather than into synthetic pathways that require hexosamines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10806197     DOI: 10.1074/jbc.M001049200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Protein O-GlcNAcylation: A critical regulator of the cellular response to stress.

Authors:  John C Chatham; Richard B Marchase
Journal:  Curr Signal Transduct Ther       Date:  2010-01

Review 2.  Protein O-GlcNAcylation in diabetes and diabetic complications.

Authors:  Junfeng Ma; Gerald W Hart
Journal:  Expert Rev Proteomics       Date:  2013-08       Impact factor: 3.940

3.  The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure.

Authors:  Rachit Badolia; Dinesh K A Ramadurai; E Dale Abel; Peter Ferrin; Iosif Taleb; Thirupura S Shankar; Aspasia Thodou Krokidi; Sutip Navankasattusas; Stephen H McKellar; Michael Yin; Abdallah G Kfoury; Omar Wever-Pinzon; James C Fang; Craig H Selzman; Dipayan Chaudhuri; Jared Rutter; Stavros G Drakos
Journal:  Circulation       Date:  2020-04-30       Impact factor: 29.690

4.  Cross-talk between GlcNAcylation and phosphorylation: site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc.

Authors:  Zihao Wang; Marjan Gucek; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-08       Impact factor: 11.205

5.  Functional regulation of glutamine:fructose-6-phosphate aminotransferase 1 (GFAT1) of Drosophila melanogaster in a UDP-N-acetylglucosamine and cAMP-dependent manner.

Authors:  H R Graack; U Cinque; H Kress
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

6.  O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability.

Authors:  X Yang; K Su; M D Roos; Q Chang; A J Paterson; J E Kudlow
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

Review 7.  O-GlcNAc signaling in the cardiovascular system.

Authors:  Gladys A Ngoh; Heberty T Facundo; Ayesha Zafir; Steven P Jones
Journal:  Circ Res       Date:  2010-07-23       Impact factor: 17.367

Review 8.  Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.

Authors:  Victor M Darley-Usmar; Lauren E Ball; John C Chatham
Journal:  J Mol Cell Cardiol       Date:  2011-08-22       Impact factor: 5.000

Review 9.  O-GlcNAc signaling: a metabolic link between diabetes and cancer?

Authors:  C Slawson; R J Copeland; G W Hart
Journal:  Trends Biochem Sci       Date:  2010-05-11       Impact factor: 13.807

Review 10.  O-GlcNAc and the cardiovascular system.

Authors:  Sujith Dassanayaka; Steven P Jones
Journal:  Pharmacol Ther       Date:  2013-11-25       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.